Glaucoma is complicated and it has finally been recognized that elevated IOP is not the only risk factor for progression. An entire menu of risk factors is now available.
Dale K. Heuer, MD, discussed the factors that can be considered easily by physicians when evaluating their patients during his Shaffer-Hetherington-Hoskins Lecture Keynote address, titled “Risk Factors for Glaucoma Progression,” at the Glaucoma 360 annual meeting.
“Every patient should undergo risk calculation to determine management, treatment, and follow-up,” said Dr. Heuer, a retired professor and chair of ophthalmology, Medical College of Wisconsin, Milwaukee.
The frequency of visits and testing is important and facilitates the advisability of escalating or deescalating treatment more, adjusting target IOPs, and perhaps reducing costs. IOP remains the biggest risk factor that is treated.